Regression of metastatic vipoma with somatostatin analogue SMS 201-995.
作者信息
Clements D, Elias E
出版信息
Lancet. 1985 Apr 13;1(8433):874-5. doi: 10.1016/s0140-6736(85)92235-4.
PMID:2858733
Abstract
摘要
相似文献
1
Regression of metastatic vipoma with somatostatin analogue SMS 201-995.
Lancet. 1985 Apr 13;1(8433):874-5. doi: 10.1016/s0140-6736(85)92235-4.
2
Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases.
Gastroenterology. 1985 Jan;88(1 Pt 1):185-7. doi: 10.1016/s0016-5085(85)80153-0.
3
[Successful therapy of VIPoma with the long-acting somatostatin analogue SMS 201-995].
Nihon Naika Gakkai Zasshi. 1988 Jan;77(1):86-90. doi: 10.2169/naika.77.86.
4
Pseudopancreatic cholera syndrome: effect of a synthetic somatostatin analogue, SMS 201-995.
Am J Med. 1987 May 29;82(5B):84-7. doi: 10.1016/0002-9343(87)90431-1.
5
The somatostatin analogue SMS 201-995 in long-term treatment of vipoma. Case report.生长抑素类似物SMS 201-995用于血管活性肠肽瘤的长期治疗。病例报告。
Acta Chir Scand. 1989 Oct;155(10):541-3.
6
Somatostatin analogue SMS 201-995 long term therapy for vipoma.生长抑素类似物SMS 201-995对血管活性肠肽瘤的长期治疗
Postgrad Med J. 1987 Apr;63(738):287-9. doi: 10.1136/pgmj.63.738.287.
7
Can inhibition of hormone secretion be associated with endocrine tumour shrinkage?激素分泌的抑制与内分泌肿瘤缩小有关吗？
Lancet. 1983;2(8365-66):1501. doi: 10.1016/s0140-6736(83)90847-4.
8
Escape of the response to a long-acting somatostatin analogue (SMS 201-995) in patients with VIPoma.
Gastroenterology. 1987 Feb;92(2):527-31. doi: 10.1016/0016-5085(87)90153-3.
9
10
Somatostatin and analogues in the treatment of VIPoma.
Ann N Y Acad Sci. 1988;527:528-35. doi: 10.1111/j.1749-6632.1988.tb27006.x.
引用本文的文献
1
Vasoactive Intestinal Peptide Tumor as the Cause of Persistent Diarrhea: A Diagnostic Challenge.血管活性肠肽瘤导致的持续性腹泻：一项诊断挑战。
Cureus. 2022 Sep 13;14(9):e29130. doi: 10.7759/cureus.29130. eCollection 2022 Sep.
2
New therapeutic approaches to metastatic gastroenteropancreatic neuroendocrine tumors: A glimpse into the future.转移性胃肠胰神经内分泌肿瘤的新治疗方法：展望未来。
World J Gastrointest Oncol. 2017 Jan 15;9(1):4-20. doi: 10.4251/wjgo.v9.i1.4.
3
Antitumor effects of somatostatin analogs in neuroendocrine tumors.生长抑素类似物在神经内分泌肿瘤中的抗肿瘤作用。
Oncologist. 2012;17(6):747-55. doi: 10.1634/theoncologist.2011-0458. Epub 2012 May 24.
4
The treatment of neuroendocrine tumors with long-acting somatostatin analogs: a single center experience with lanreotide autogel.长效生长抑素类似物治疗神经内分泌肿瘤：兰瑞肽微球的单中心经验。
J Endocrinol Invest. 2011 Oct;34(9):692-7. doi: 10.3275/8058. Epub 2011 Nov 7.
5
Hepatic resection for metastatic gastrointestinal and pancreatic neuroendocrine tumours: outcome and prognostic predictors.肝脏切除术治疗转移性胃肠道和胰腺神经内分泌肿瘤：结果和预后预测因素。
HPB (Oxford). 2007;9(5):345-51. doi: 10.1080/13651820701504199.
6
Alkaline phosphatase predicts survival in patients with metastatic neuroendocrine tumors.
Dig Dis Sci. 2006 May;51(5):877-84. doi: 10.1007/s10620-006-9345-4. Epub 2006 Jun 7.
7
Somatostatin analog therapy in treatment of gastrointestinal disorders and tumors.生长抑素类似物疗法在胃肠道疾病和肿瘤治疗中的应用
Endocrine. 2003 Apr;20(3):285-90. doi: 10.1385/ENDO:20:3:285.
8
Vasoactive intestinal polypeptide-secreting tumor (VIPoma) with liver metastases: dramatic and durable symptomatic benefit from hepatic artery embolization, a case report.伴有肝转移的血管活性肠肽分泌瘤（VIPoma）：肝动脉栓塞术带来显著且持久的症状改善，病例报告
Med Oncol. 2002;19(3):181-7. doi: 10.1385/MO:19:3:181.
9
Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.生长抑素类似物奥曲肽与转移性内分泌胃肠胰腺肿瘤的肿瘤生长抑制
Gut. 1996 Mar;38(3):430-8. doi: 10.1136/gut.38.3.430.
10
Somatostatin analog sandostatin and inhibition of tumor growth in patients with metastatic endocrine gastroenteropancreatic tumors.生长抑素类似物善宁与转移性内分泌胃肠胰腺肿瘤患者肿瘤生长的抑制
World J Surg. 1993 Jul-Aug;17(4):511-9. doi: 10.1007/BF01655111.
Zotero 插件